PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för enrasentan. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

15 hits

Bibliografisk träff 2005-12-09

Comparison of the dual receptor endothelin antagonist enrasentan with enalapril in asymptomatic left ventricular systolic dysfunction: a cardiovascular magnetic resonance study.

Prasad SK, Dargie HJ, Smith GC, Barlow MM, Grothues F, Groenning BA, Cleland JG, Pennell DJ.

Heart · clinical trial, phase ii; comparative study; research support, non-u.s. gov't; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.1136/hrt.2004.049734

Bibliografisk träff 2003-01-01

Enrasentan, an antagonist of endothelin receptors.

Cosenzi A.

Cardiovasc Drug Rev · review; journal article · DOI 10.1111/j.1527-3466.2003.tb00102.x

Bibliografisk träff 2002-11-01

An endothelin receptor antagonist, SB-217242, inhibits airway hyperresponsiveness in allergic mice.

Henry PJ, Mann TS, D'Aprile AC, Self GJ, Goldie RG.

Am J Physiol Lung Cell Mol Physiol · research support, non-u.s. gov't; journal article · DOI 10.1152/ajplung.00076.2002

Bibliografisk träff 2002-04-01

Antihypertensive treatment with enrasentan (SB217242) in an animal model of hypertension and hyperinsulinemia.

Cosenzi A, Bernobich E, Bonavita M, Bertola G, Trevisan R, Bellini G.

J Cardiovasc Pharmacol · journal article · DOI 10.1097/00005344-200204000-00004

Bibliografisk träff 2001-10-01

Enrasentan improves survival, limits left ventricular remodeling, and preserves myocardial performance in hypertensive cardiac hypertrophy and dysfunction.

Willette RN, Anderson KM, Nelson AH, Olzinski AR, Woods T, Coatney RW, Aiyar N, Ohlstein EH, Barone FC.

J Cardiovasc Pharmacol · journal article · DOI 10.1097/00005344-200110000-00013

Bibliografisk träff 2000-11-01

Unmasking of endothelin-1-induced natriuresis and renal vasodilation in the dog by enrasentan (SB 217242).

Brooks DP, DePalma PD.

J Cardiovasc Pharmacol · journal article · DOI 10.1097/00005344-200036051-00100

Bibliografisk träff 1999-07-01

Enrasetan. SB 217242.

Författaruppgift saknas

Drugs R D · journal article · DOI 10.2165/00126839-199902010-00005

Bibliografisk träff 1999-01-01

Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive rat.

Underwood DC, Bochnowicz S, Osborn RR, Luttmann MA, Louden CS, Hart TK, Elliott JD, Hay DW.

Pulm Pharmacol Ther · journal article · DOI 10.1006/pupt.1999.0158

Bibliografisk träff 1999-01-01

Developmental toxicity and toxicokinetics of two endothelin receptor antagonists in rats and rabbits.

Treinen KA, Louden C, Dennis MJ, Wier PJ.

Teratology · journal article · DOI 10.1002/(sici)1096-9926(199901)59:1<51::aid-tera10>3.0.co;2-i

Bibliografisk träff 1998-06-01

Application of serial in vivo magnetic resonance imaging to evaluate the efficacy of endothelin receptor antagonist SB 217242 in the rat carotid artery model of neointima formation.

Chandra S, Clark LV, Coatney RW, Phan L, Sarkar SK, Ohlstein EH.

Circulation · journal article · DOI 10.1161/01.cir.97.22.2252

Bibliografisk träff 1998-01-01

Application of magnetic resonance imaging for evaluation of the efficacy of SB 217242 in neointimal formation.

Chandra S, Sarkar S, Elliot JD, Ohlstein EH.

J Cardiovasc Pharmacol · journal article · DOI 10.1097/00005344-199800001-00088

Bibliografisk träff 1998-01-01

Chronic hypoxia-induced cardiopulmonary changes in three rat strains: inhibition by the endothelin receptor antagonist SB 217242.

Underwood DC, Bochnowicz S, Osborn RR, Louden CS, Hart TK, Ohlstein EH, Hay DW.

J Cardiovasc Pharmacol · journal article · DOI 10.1097/00005344-199800001-00129

Bibliografisk träff 1997-12-01

Nonpeptide endothelin receptor antagonists. X. Inhibition of endothelin-1- and hypoxia-induced pulmonary pressor responses in the guinea pig by the endothelin receptor antagonist, SB 217242.

Underwood DC, Bochnowicz S, Osborn RR, Luttmann MA, Hay DW.

J Pharmacol Exp Ther · journal article · DOI 10.1016/s0022-3565(24)37169-1

Bibliografisk träff 1996-02-01

Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.

Ohlstein EH, Nambi P, Lago A, Hay DW, Beck G, Fong KL, Eddy EP, Smith P, Ellens H, Elliott JD.

J Pharmacol Exp Ther · journal article · DOI 10.1016/s0022-3565(25)12314-8

Bibliografisk träff 1995-01-01

The endothelin receptor antagonist SB 217242 reduces cerebral focal ischemic brain injury.

Barone FC, White RF, Elliott JD, Feuerstein GZ, Ohlstein EH.

J Cardiovasc Pharmacol · journal article · DOI 10.1097/00005344-199506263-00119